S&P DJI Announces March 2023 Quarterly Rebalance
Filed with ASX · · 8 pages · English
Medical Developments International Limited on 6ix
Story so far
Earlier from Medical Developments International
- 2023 Half Year Presentation
- 2023 Half Year Report (including 4D)
- 2023 Half Year ASX Announcement
- China Clinical Trials Discontinued
- Chair and CEO Presentation to Shareholders
Later from Medical Developments International
- US Penthrox Strategy
- Response to ASX Price Query
- MVP Announces FY23 Full Year Results
- FY23 Full Year Accounts
- FY23 Full Year Results Investor Presentation
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International